Products Categories
| CAS No.: | 15375-94-7 |
|---|---|
| Name: | Mersalyl |
| Molecular Structure: | |
|
|
|
| Formula: | C34H34 Hg N4 O6 . 2 Na |
| Molecular Weight: | 841.29 |
| Synonyms: | Mercurate(2-),[7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N21,N22,N23,N24]-,disodium, (SP-4-2)-; Mercury, [dihydrogen7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-2,18-porphinedipropionate(1-)]-,disodium salt (8CI); 21H,23H-Porphine-2,18-dipropanoic acid,7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-, mercury complex; Merphyrin;NSC 66393 |
| Density: | g/cm3 |
| Boiling Point: | 1180.2°Cat760mmHg |
| Flash Point: | 667.6°C |
| Safety: | Poison by intraperitoneal, subcutaneous, intravenous, and intracerebral routes. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of Hg and NOx. See also MERCURY COMPOUNDS, INORGANIC; MERCURY COMPOUNDS, ORGANIC. |
| PSA: | 134.78000 |
| LogP: | 1.14290 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 173606-50-3BOC-10-AMINODECANOIC ACID
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 211914-50-0N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
- Total:4 Page 1 of 1 1
What can I do for you?
Get Best Price
Chemistry
CAS: 15375-94-7
Following is the Molecular Structure of Hematoporphyrin mercury disodium salt (15375-94-7):
SMILES: [Hg+2].[Na+].[Na+].[O-]C(=O)CCc1c(c3[n-]c1cc2[n-]c(c(c2CCC([O-])=O)C)cc/5nc(cc\4nc(c3)/C(=C/4C)C(O)C)\C(=C\5C)C(O)C)C
InChI: InChI=1/C34H38N4O6.Hg.2Na/c1-15-21(7-9-31(41)42)27-14-28-22(8-10-32(43)44)16(2)24(36-28)12-29-34(20(6)40)18(4)26(38-29)13-30-33(19(5)39)17(3)25(37-30)11-23(15)35-27;;;/h11-14,19-20,39-40H,7-10H2,1-6H3,(H4,35,36,37,38,41,42,43,44);;;/q;+2;2*+1/p-4/b23-11-,24-12-,25-11-,26-13-,27-14-,28-14-,29-12-,30-13-;;;
InChIKey: MSWKATKSSLJVEX-QBVPMRDMBI
Std.InChI: InChI=1S/C34H38N4O6.Hg.2Na/c1-15-21(7-9-31(41)42)27-14-28-22(8-10-32(43)44)16(2)24(36-28)12-29-34(20(6)40)18(4)26(38-29)13-30-33(19(5)39)17(3)25(37-30)11-23(15)35-27;;;/h11-14,19-20,39-40H,7-10H2,1-6H3,(H4,35,36,37,38,41,42,43,44);;;/q;+2;2*+1/p-4/b23-11-,24-12-,25-11-,26-13-,27-14-,28-14-,29-12-,30-13-;;;
Std.InChIKey: MSWKATKSSLJVEX-HRSUBPLTSA-J
Molecular Formula: C34H34HgN4Na2O6
Molecular Weight: 841.2265
Boiling Point: 1180.2℃ at 760mmHg
Flash Point: 667.6℃
Enthalpy of Vaporization: 183kJ/mol
Vapour Pressure: 0mmHg at 25℃
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intracrebral | 380ug/kg (0.38mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 57, Pg. 219, 1961. |
| mouse | LD50 | intraperitoneal | 23mg/kg (23mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 57, Pg. 219, 1961. |
| mouse | LD50 | intravenous | 11500ug/kg (11.5mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 57, Pg. 219, 1961. |
| mouse | LD50 | subcutaneous | 30mg/kg (30mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 57, Pg. 219, 1961. |
Consensus Reports
Mercury and its compounds are on the Community Right-To-Know List.
Safety Profile
Poison by intraperitoneal, subcutaneous, intravenous, and intracerebral routes. Experimental reproductive effects.
Standards and Recommendations
OSHA PEL: CL 0.1 mg(Hg)/m3 (skin)
ACGIH TLV: TWA 0.1 mg(Hg)/m3 (skin); BEI: 35 µg/g creatinine total inorganic mercury in urine preshift; 15 µg/g creatinine total inorganic mercury in blood at end of shift at end of workweek.
DFG MAK: Confirmed Animal Carcinogen with Unknown Relevance to Humans
NIOSH REL: (Mercury, Organo) TWA 0.01 mg/m3; STEL 0.03 mg/m3 (skin)
Specification
Hematoporphyrin mercury disodium salt (15375-94-7) also can be called for Hematoporphyrin mercury (II) ; Hematoporphyrin, mercury(II) deriv. ; Disodium salt ; Hematoporphyrinmercury disodium salt ; Hg-Hematoporphyrin-NA ; Mercuri-hematoporphyrin disodium salt ; Merphyllin ; Merphyrin .When Hematoporphyrin mercury disodium salt (15375-94-7) was heated,it emits very toxic fumes of Hg and NOx .